Emotion Regulation Trajectories at Ages 3 to 7 Years Tied to ADHD Symptoms at 7 Years
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Trajectories of emotion regulation across ages 3 to 7 years predict attention-deficit/hyperactivity disorder (ADHD) symptoms, as well as conduct problems, according to a study recently published online in Development and Psychopathology.
Aja Louise Murray, Ph.D., from the University of Edinburgh in the United Kingdom, and colleagues used data from more than 19,000 children in the U.K.-based Millennium Cohort Study to evaluate whether developmental trajectories of emotion regulation across ages 3, 5, and 7 years predict levels of ADHD symptoms, internalizing problems, and conduct problems at age 7 years.
The researchers found that both higher initial levels of and slower reductions in emotion dysregulation across ages 3, 5, and 7 years predicted higher ADHD symptoms, conduct problems, and internalizing problems at age 7 years. Findings were seen in both male and female children.
"Emotion regulation skills are acquired from early in life and are thought to strengthen gradually over childhood. Children, however, acquire these skills at different rates and slower acquisition may serve as a marker for neurodevelopmental and mental health issues," Murray said in a statement. "Our findings suggest that monitoring trajectories of emotion regulation over development could help identify which children are at risk of mental health issues."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Insomnia Plays a Role in Quality of Life for Patients With ADHD
MONDAY, July 21, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) symptoms are associated with lower quality of life (QoL) in adults, and this association is only partially...
ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes
WEDNESDAY, July 2, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world outcomes, but the magnitude of...
Onset of Sepsis in First Week of Life Tied to Increased Likelihood of Autism Spectrum Disorder
TUESDAY, June 24, 2025 -- Early-onset neonatal sepsis is associated with increased likelihood autism spectrum disorder (ASD) and of attention-deficit/hyperactivity disorder...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.